BKV Corp Files 8-K: Regulation FD & Financials

TL;DR

BKV Corp filed an 8-K on Dec 2 for Dec 1 event - Reg FD & Financials update.

AI Summary

BKV Corporation filed an 8-K on December 2, 2025, reporting an event on December 1, 2025. The filing pertains to Regulation FD Disclosure and Financial Statements and Exhibits. BKV Corporation, incorporated in Delaware, is in the Crude Petroleum & Natural Gas industry.

Why It Matters

This 8-K filing indicates BKV Corporation is providing updates on regulatory disclosures and financial statements, which are important for investors to understand the company's current standing and compliance.

Risk Assessment

Risk Level: low — This filing is a standard 8-K for regulatory and financial disclosures, not indicating any immediate operational or financial distress.

Key Numbers

• 001-42282 — SEC File Number (Identifies the company's filing with the SEC.)
• 85-0886382 — EIN (Employer Identification Number for tax purposes.)

Key Players & Entities

• BKV Corporation (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• CRUDE PETROLEUM & NATURAL GAS (industry) — Standard Industrial Classification
• Denver, Colorado (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share BKV New York Stock Exchan
• $26.00 — Offering at a public offering price of $26.00 per share of its common stock. The Comp

Filing Documents

• tm2532509d1_8k.htm (8-K) — 27KB
• tm2532509d1_ex99-1.htm (EX-99.1) — 16KB
• tm2532509d1_ex99-2.htm (EX-99.2) — 18KB
• tm2532509d1_ex99-1img001.jpg (GRAPHIC) — 13KB
• tm2532509d1_ex99-2img001.jpg (GRAPHIC) — 10KB
• 0001104659-25-117490.txt ( ) — 269KB
• bkv-20251201.xsd (EX-101.SCH) — 3KB
• bkv-20251201_lab.xml (EX-101.LAB) — 33KB
• bkv-20251201_pre.xml (EX-101.PRE) — 22KB
• tm2532509d1_8k_htm.xml (XML) — 4KB

01. Regulation FD

Item 7.01. Regulation FD Disclosure. On December 1, 2025, BKV Corporation (the "Company") issued a press release announcing the commencement of an underwritten public offering by the Company of 6,000,000 shares of its common stock (the "Equity Offering"). A copy of such press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. Also on December 1, 2025, the Company issued a press release announcing the pricing of the Equity Offering at a public offering price of $26.00 per share of its common stock. The Company has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares from the Company at the public offering price, less underwriting discounts and commissions. A copy of such press release is attached hereto as Exhibit 99.2 and incorporated by reference herein. This Current Report Form 8-K is neither an offer to sell nor a solicitation of an offer to buy any security, including the Company's common stock, nor a solicitation for an offer to purchase any security, including the Company's common stock. The information furnished in this Item 7.01 (including Exhibit 99.1 and Exhibit 99.2) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act.

01. Financial

Item 9.01. Financial (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated December 1, 2025, announcing the Equity Offering. 99.2 Press Release, dated December 1, 2025, announcing the pricing of the Equity Offering. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BKV Corporation December 2, 2025 By: /s/ David R. Tameron David R. Tameron Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR